Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael J Sorich

Showing results (1-10 of 186) with videos related to

Pageof 19
Sort By:
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|October 3, 2022
Response to Mazzaschi and ButiAshley M Hopkins, Michael J Sorich
Current Drug Metabolism|May 18, 2012
Personalized medicine: potential, barriers and contemporary issuesMichael J Sorich, Ross A McKinnon
Clinical Pharmacology and Therapeutics|September 16, 2022
The Broader Context of Liquid Biopsy in Absorption, Distribution, Metabolism, and EliminationAndrew Rowland, Zivile Useckaite, Michael J Sorich
BMC Medicine|September 29, 2018
Data sharing from pharmaceutical industry sponsored clinical studies: audit of data availabilityAshley M Hopkins, Andrew Rowland, Michael J Sorich
Therapeutic Advances in Drug Safety|August 2, 2014
Pharmacogenomic substudies of randomized controlled trials: consideration of safety outcomesMichael J Sorich, Andrew Rowland, Michael D Wiese
Journal of Clinical Medicine|July 3, 2020
Role of Extracellular Vesicles in the Pathophysiology, Diagnosis and Tracking of Non-Alcoholic Fatty Liver DiseaseLauren A Newman, Michael J Sorich, Andrew Rowland
JAMA Oncology|April 24, 2020
Obesity Paradox in Patients With Non-Small Cell Lung Cancer Treated With Immunotherapy-ReplyGanessan Kichenadasse, Ashley M Hopkins, Michael J Sorich
Melanoma Research|August 20, 2019
Validation of dabrafenib-trametinib prognostic groups in patients treated with vemurafenib and cobimetinib for advanced BRAF-mutated melanomaMichael J Sorich, Andrew Rowland, Ashley M Hopkins
Pharmacogenomics|June 5, 2014
Cost-effectiveness of genotyping to guide treatmentMichael J Sorich, Michael D Wiese, Brita Pekarsky
European Urology|September 22, 2020
Reply to Satoshi Funada, Takashi Yoshioka, and Yan Luo's Letter to the Editor re: Ashley M. Hopkins, Ganessan Kichenadasse, Christos S. Karapetis, et al. Concomitant Antibiotic Use and Survival in Urothelial Carcinoma Treated with Atezolizumab. Eur Urol 2020;78:540-3Ashley M Hopkins, Ganessan Kichenadasse, Michael J Sorich
Pageof 19

Showing results (1-10 of 186) with videos related to

Sort By:
Pageof 19
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|October 3, 2022
Response to Mazzaschi and ButiAshley M Hopkins, Michael J Sorich
Current Drug Metabolism|May 18, 2012
Personalized medicine: potential, barriers and contemporary issuesMichael J Sorich, Ross A McKinnon
Clinical Pharmacology and Therapeutics|September 16, 2022
The Broader Context of Liquid Biopsy in Absorption, Distribution, Metabolism, and EliminationAndrew Rowland, Zivile Useckaite, Michael J Sorich
BMC Medicine|September 29, 2018
Data sharing from pharmaceutical industry sponsored clinical studies: audit of data availabilityAshley M Hopkins, Andrew Rowland, Michael J Sorich
Therapeutic Advances in Drug Safety|August 2, 2014
Pharmacogenomic substudies of randomized controlled trials: consideration of safety outcomesMichael J Sorich, Andrew Rowland, Michael D Wiese
Journal of Clinical Medicine|July 3, 2020
Role of Extracellular Vesicles in the Pathophysiology, Diagnosis and Tracking of Non-Alcoholic Fatty Liver DiseaseLauren A Newman, Michael J Sorich, Andrew Rowland
JAMA Oncology|April 24, 2020
Obesity Paradox in Patients With Non-Small Cell Lung Cancer Treated With Immunotherapy-ReplyGanessan Kichenadasse, Ashley M Hopkins, Michael J Sorich
Melanoma Research|August 20, 2019
Validation of dabrafenib-trametinib prognostic groups in patients treated with vemurafenib and cobimetinib for advanced BRAF-mutated melanomaMichael J Sorich, Andrew Rowland, Ashley M Hopkins
Pharmacogenomics|June 5, 2014
Cost-effectiveness of genotyping to guide treatmentMichael J Sorich, Michael D Wiese, Brita Pekarsky
European Urology|September 22, 2020
Reply to Satoshi Funada, Takashi Yoshioka, and Yan Luo's Letter to the Editor re: Ashley M. Hopkins, Ganessan Kichenadasse, Christos S. Karapetis, et al. Concomitant Antibiotic Use and Survival in Urothelial Carcinoma Treated with Atezolizumab. Eur Urol 2020;78:540-3Ashley M Hopkins, Ganessan Kichenadasse, Michael J Sorich
Pageof 19